Bayer’s BlueRock Therapeutics widens cell therapy scope to the eye under new pact

BlueRock Therapeutics, a Bayer subsidiary, is teaming up with Opsis Therapeutics and Fujifilm Cellular Dynamics in an R&D pact focused on developing stem cell therapies for eye diseases. BlueRock is paying its new partners $30 million up front to kick off the alliance. Source: Bayer’s BlueRock Therapeutics widens cell therapy scope to the eye under […]

How AI may hold the key to faster rare disease diagnosis

Leveraging artificial intelligence can shave years off the difficult process of diagnosing a rare disease. By safely sharing patient data, more will benefit globally. Source: How AI may hold the key to faster rare disease diagnosis

Accumulated genetic variations: What they are and why they matter to a complete health picture

Unlike inherited genetic predispositions, accumulated genetic changes are the result of environmental influences, such as smoking, chemicals or ultra-violet radiation. A growing body of research links somatic changes to an increased likelihood of blood cancers and cardiovascular disease, both heart disease and stroke. Source: Accumulated genetic variations: What they are and why they matter to […]

Artificial Intelligence improves Brain tumour diagnosis

A new machine learning approach can classify gliomas, a common type of brain tumour, into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access. Source: Artificial Intelligence improves Brain tumour diagnosis